T1	Participants 84 106	advanced breast cancer
T2	Participants 147 248	From January 1985 to September 1988, 60 women with advanced breast cancer were randomized in two arms
T3	Participants 485 676	All patients were post-menopausal, previously untreated with hormone therapy, and with tumor receptor status determined immediately before randomization; all had objectively evaluable lesions
T4	Participants 833 902	Thirty-one and 29 patients were included respectively in arms A and B
